Clinical Professor David Smith studied Medicine at The University of Western Australia, and trained as a Medical Microbiologist/Virologist in Perth, where he currently works as a Medical Microbiologist at PathWest Laboratory Medicine WA (PathWest), and as Director of the QE2 Medical Centre PathWest Network. He is also a Clinical Professor in the School of Biomedical Sciences at the University of Western Australia, and is Director of the National Influenza Centre and of the Arbovirus Research and Surveillance Unit at PathWest.
Professor Smith serves on many state, national and international committees and advisory groups, including those advising on pandemic influenza, Zika virus and Ebola responses. He is currently Chair of the National Arbovirus and Malaria Advisory Committee, the peak government advisory committee on arboviruses. He has also served two terms as Chair of the national Public Health Laboratory Network, and has been actively involved in the laboratory responses to bioterrorist agents, SARS, MERS, avian and pandemic influenza, Ebola and other emerging threats.
He has a particular interest in public health issues, including mosquito-borne viruses, influenza and other respiratory viruses, emerging infections, new diagnostic technologies, and laboratory-based surveillance. Professor Smith has authored or co-authored more than 170 book chapters and medical journal articles, as well as many conference presentations.
Research Leader of
- Developing Australasia’s serological capability for viral haemorrhagic fevers
- Development and evaluation of a carbon dioxide-free system for mosquito-borne disease surveillance
- Establishing a national biobank for COVID-19
- Improved detection and characterisation of flaviviruses and their antibodies in humans, animals and mosquitoes
- Influenza sero-surveillance at the animal-human interface: a feasibility study in high-risk groups
- Sampling, shipping and serology: a proof of concept study of influenza immunity
- Key lessons from the COVID-19 public health response in Australia
- Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-specific antibodies in Australia after the first epidemic wave in 2020: A national survey
- Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
- The challenges of establishing adequate capacity for SARS‐CoV‐2 testing
- Genome sequence analysis of first Ross River virus isolate from Papua New Guinea indicates long-term, local evolution
- Phylogenetic and timescale analysis of Barmah Forest virus as inferred from genome sequence analysis
- Genome-scale phylogeny and evolutionary analysis of Ross River virus reveals periodic sweeps of lineage dominance in Western Australia, 1977-2014
- Respiratory illness in a piggery associated with the first identified outbreak of swine influenza in Australia: Assessing the risk to human health and zoonotic potential
- The impact of influenza infection on young children, their family and the health care system
- Divergent human origin influenza viruses detected in Australian swine populations
- Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case-control study protocol